A new study from New York-based insurer Emblem Health provides evidence suggesting that inpatient point-of-care case management can both reduce patient hospital readmissions and provide a solid return ...
New Data From EMBLEM(TM) Study Show Pipeline Drug Epratuzumab Provided Significant Efficacy for Patients Suffering From Moderate to Severe Systemic Lupus Erythematosus Statistically significant* and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback